Carson Wealth (CWM LLC)’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.7K	Buy	+702	New	+$32.5K	﹤0.01%	4144
2022 Q4	–	Sell	-243	Closed	-$12K	–	4078
2022 Q3	$12K	Hold	243	–	–	﹤0.01%	2563
2022 Q2	$12K	Hold	243	–	–	﹤0.01%	2462
2022 Q1	$15K	Hold	243	–	–	﹤0.01%	2250
2021 Q4	$19K	Buy	+243	New	+$20.4K	﹤0.01%	2020
2021 Q2	$24K	Hold	243	–	–	﹤0.01%	1707
2021 Q1	$24K	Hold	243	–	–	﹤0.01%	1707
2020 Q4	$24K	Hold	243	–	–	﹤0.01%	1707
2020 Q3	$24K	Hold	243	–	–	﹤0.01%	1707
2020 Q2	$24K	Hold	243	–	–	﹤0.01%	1707
2020 Q1	$24K	Hold	243	–	–	﹤0.01%	1707
2019 Q4	$24K	Hold	243	–	–	﹤0.01%	1707
2019 Q3	$24K	Hold	243	–	–	﹤0.01%	1707
2019 Q2	$24K	Buy	+243	New	+$13.8K	﹤0.01%	1707

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Carson Wealth (CWM LLC)'s GNOM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026: 702 shares worth $30.7K. The stake represents ﹤0.01% of the portfolio and ranks #4144 among its holdings. This is a return to the name: Carson Wealth (CWM LLC) previously reported a position in GNOM as recently as Q3 2022.

Carson Wealth (CWM LLC) first reported a position in GNOM in Q2 2019 and has held it in 14 quarters since. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

Carson Wealth (CWM LLC) held 702 shares of Global X Genomics & Biotechnology ETF worth $30.7K as of Q1 2026.
Global X Genomics & Biotechnology ETF was a new Carson Wealth (CWM LLC) position in Q1 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4144 holding.
Carson Wealth (CWM LLC) first reported a position in Global X Genomics & Biotechnology ETF in Q2 2019 and has held it in 14 quarters since.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.